EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into the pathophysiology of DFNA44 hearing loss associated with CCDC50 frameshift variants

María Lachgar-Ruiz iD, Matías Morín iD, Elisa Martelletti iD, Neil J Ingham iD, Lorenzo Preite, Morag A Lewis iD, Luciana Santos Serrão de Castro, Karen P Steel iD, Miguel Ángel Moreno-Pelayo iD

Disease Models & Mechanisms · 2023

DOI: 10.1242/dmm.049757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2023. Verfasst von María Lachgar-Ruiz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London SE1 1UL, UK. Hauptthemen laut MEDLINE: Hearing Loss, Sensorineural, Hearing Loss. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIMHD NIH HHS, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-syndromic sensorineural hearing loss (SNHL) is the most common sensory disorder, and it presents a high genetic heterogeneity. As part of our clinical genetic studies, we ascertained a previously unreported mutation in CCDC50 [c.828_858del, p.(Asp276Glufs*40)] segregating with hearing impairment in a Spanish family with SNHL associated with the autosomal dominant deafness locus DFNA44, which is predicted to disrupt protein function. To gain insight into the mechanism behind DFNA44 mutations, we analysed two Ccdc50 presumed loss-of-function mouse mutants, which showed normal hearing thresholds up to 6 months of age, indicating that haploinsufficiency is unlikely to be the pathogenic mechanism. We then carried out in vitro studies on a set of artificial mutants and on the p.(Asp276Glufs*40) and p.(Phe292Hisfs*37) human mutations, and determined that only the mutants containing the six-amino-acid sequence CLENGL as part of their aberrant protein tail showed an abnormal distribution consisting of perinuclear aggregates of the CCDC50 protein (also known as Ymer). Therefore, we conclude that the CLENGL sequence is necessary to form these aggregates. Taken together, the in vivo and in vitro results obtained in this study suggest that the two identified mutations in CCDC50 exert their effect through a dominant-negative or gain-of-function mechanism rather than by haploinsufficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing Loss, SensorineuralHearing LossHumansAnimalsMiceFrameshift MutationMutationPedigreeIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

CCDC50DFNA44DeafnessMouse mutantNext-generation sequencingProgressive hearing lossYmer

Substanzen

CCDC50 protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London SE1 1UL, UK.
  • Servicio de Genética, Hospital Universitario Ramón y Cajal, IRYCIS and Biomedical Network Research Centre on Rare Diseases (CIBERER), km 9.100, 28034 Madrid, Spain.

ORCID-Profile: María Lachgar-Ruiz, Matías Morín, Elisa Martelletti, Neil J Ingham, Morag A Lewis, Karen P Steel, Miguel Ángel Moreno-Pelayo

Förderung

  • Wellcome Trust
  • NIMHD NIH HHS
  • Instituto de Salud Carlos III
  • Spanish National Plan for Scientific and Technical Research and Innovation
  • Comunidad de Madrid
  • Royal National Institute for Deaf People
  • Ciência sem Fronteiras
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Lachgar-Ruiz, M., Morín, M., Martelletti, E., Ingham, N. J., Preite, L., Lewis, M. A., Serrão de Castro, L. S., Steel, K. P., & Moreno-Pelayo, M. Á. (2023). Insights into the pathophysiology of DFNA44 hearing loss associated with CCDC50 frameshift variants. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.049757

Vancouver

Lachgar-Ruiz M, Morín M, Martelletti E, Ingham NJ, Preite L, Lewis MA, et al. Insights into the pathophysiology of DFNA44 hearing loss associated with CCDC50 frameshift variants. Disease Models & Mechanisms. 2023. doi:10.1242/dmm.049757

BibTeX
@article{LachgarRuiz2023,
  author = {Lachgar-Ruiz, María and Morín, Matías and Martelletti, Elisa and Ingham, Neil J and Preite, Lorenzo and Lewis, Morag A and Serrão de Castro, Luciana Santos and Steel, Karen P and Moreno-Pelayo, Miguel Ángel},
  title = {Insights into the pathophysiology of DFNA44 hearing loss associated with CCDC50 frameshift variants},
  journal = {Disease Models & Mechanisms},
  year = {2023},
  doi = {10.1242/dmm.049757}
}
Kostenlos starten →